T

he U.S. may be gripped by an opioid crisis, but a new report suggests the various measures undertaken to fight the scourge is having an effect — fewer prescriptions were written for the addictive painkillers.

To wit, opioid prescriptions declined by 10.2 percent in 2017 and prescriptions for the highest doses fell by 16.1 percent last year, and 33.1 percent since January 2016. Moreover, on average, prescription opioid volume has decreased every year over the past five years in all 50 states, according to data from the IQVIA Institute for Human Data Science, which is part of the IQVIA market research firm.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy